Skip to main content

Pharma Complaint Hub

Pharma Complaint Hub logo
Cosmetic Safety Operations

Cosmetovigilance Services

Structured operational support for undesirable health effects, serious reactions, consumer-safety information, follow-up, authorized assessment preparation, reporting support, case reconciliation and post-market trend monitoring.

Service Overview

Post-Market Safety Support for Cosmetic Products

Cosmetovigilance focuses on collecting, documenting, reviewing and monitoring reports of undesirable health effects associated with cosmetic products after they reach consumers.

We support the operational activities needed to preserve the source report, identify missing information, prepare complete safety records, coordinate follow-up, support authorized assessment and reporting processes, and monitor recurring safety patterns.

Safety decision boundary: We do not independently determine medical causality, seriousness, regulatory reportability or the final relationship between a cosmetic product and an effect. Those decisions remain with the responsible organization and its authorized Safety, Medical and Regulatory personnel.
EU: Undesirable Effect

A health reaction attributed to normal or reasonably foreseeable cosmetic-product use.

EU: Serious Undesirable Effect

A report meeting the applicable EU seriousness criteria and requiring authorized notification review.

US: Cosmetic Adverse Event

An adverse health-related event associated with cosmetic-product use; serious reports follow the applicable MoCRA process.

Service Scope

Cosmetovigilance Activities We Support

Workflows can be configured around the client’s products, markets, safety procedures, reporting responsibilities, terminology, systems and authorized decision points.

Safety Information Intake

Capture and document reports received from consumers, professionals, retailers, distributors, partners, affiliates, digital channels and customer-care teams.

Reporter and Consumer Validation

Record available source, consumer, contact, country, language, permission and follow-up information using privacy-conscious controls.

Product Identification

Validate product, variant, shade, fragrance, size, presentation, batch, label, market and responsible-company information.

Effect and Outcome Documentation

Preserve the consumer’s reported symptoms, timing, treatment, outcome, healthcare interaction and product-use chronology without adding medical conclusions.

Follow-Up and Evidence

Coordinate approved questions, medical-document requests, photographs, labels, receipts, batch details and contact-attempt tracking.

Safety Trends and Reporting Support

Prepare authorized reporting records, monitor timelines, reconcile statuses, and support product, reaction, market and seriousness trends.

Operational Workflow

Cosmetovigilance Case-Handling Process

A structured process supports complete records, timely escalation, controlled follow-up, authorized review and traceable reporting or closure.

01 Receive and Register Report
02 Validate Source and Product
03 Document Effect and Chronology
04 Quality–Safety Cross-Check
05 Escalate for Authorized Review
06 Follow Up for Missing Information
07 Prepare Reporting and Reconciliation
08 Monitor Trends and Authorized Closure
Safety Record Quality

Information Captured and Validated

Required fields and follow-up priorities should align with the applicable jurisdiction, product category, seriousness criteria, client procedure and reporting responsibility.

Reporter and Consumer

  • Reporter identity, role and contact information
  • Consumer identifiers appropriate to the process
  • Country, language and source channel
  • Healthcare-professional involvement
  • Follow-up permission and preferred contact method

Cosmetic Product

  • Product, brand, variant and category
  • Shade, fragrance, size and presentation
  • Batch, lot, expiry or period-after-opening details
  • Frequency, duration and manner of use
  • Market, label and responsible-company details

Reported Health Effect

  • Symptoms in the reporter’s own words
  • Body location and onset date
  • Duration, progression and outcome
  • Treatment, medical consultation or hospitalization
  • Product discontinuation and re-use information

Context and Supporting Information

  • Relevant history and known sensitivities when provided
  • Other cosmetic or healthcare products used
  • Photographs and healthcare documentation
  • Purchase, storage and product-condition information
  • Previous similar experiences and follow-up status
Escalation Support

Serious Reaction and Urgent Review Workflows

Operational teams should identify potential seriousness or urgency indicators and escalate them without making the final medical or regulatory determination.

Potential Seriousness Indicators

Examples below support prompt escalation only. Authorized personnel apply the formal market-specific definition and determine whether the case meets reporting criteria.

  • Death or immediate life-threatening risk
  • Hospitalization or significant medical intervention
  • Disability, functional incapacity or persistent impairment
  • Congenital anomaly or other market-defined serious outcome
  • Infection, significant burns, severe allergy or eye injury

Immediate Internal Escalation

Route available information promptly to the designated Safety, Medical, Quality or Regulatory function while follow-up continues.

Day-Zero Traceability

Preserve the initial receipt and awareness history, source report, transfer date and receiving-function confirmation.

Medical Follow-Up Support

Prepare client-approved questions and document consumer, healthcare-professional and treatment information without providing medical advice.

Reporting-Readiness Tracking

Monitor required fields, labels, attachments, authorized assessment status, deadlines and submission confirmation.

Missing Information

Cosmetovigilance Follow-Up Support

Follow-up should be purposeful, privacy-conscious, documented and tailored to the missing information required for authorized assessment or reporting.

01

Question-Set Preparation

Prepare approved questions covering product use, effect chronology, treatment, outcome, healthcare contact, product identification and supporting documents.

02

Consumer and Reporter Contact

Support approved email, telephone, portal or multilingual follow-up channels with contact-attempt and outcome tracking.

03

Healthcare-Professional Follow-Up

Coordinate authorized requests for diagnosis, treatment, test, outcome or medical-document information where appropriate and permitted.

04

Response Validation

Confirm case identity, source, dates, product details and attachment linkage before updating the safety record.

05

Unsuccessful Attempt Documentation

Record attempts, channels, dates, unavailable information, stopping criteria and remaining assessment limitations.

06

Quality–Safety Coordination

Coordinate product, batch, photograph, complaint and safety questions to reduce duplicate contacts and inconsistent records.

Reporting Preparation

Jurisdiction-Aware Safety Reporting Support

Reporting terminology, responsible parties, forms, timelines and recipient authorities vary by market. The client’s approved regulatory pathway remains the source of truth.

European Union

Serious Undesirable Effect Support

EU Cosmetics Regulation Article 23 requires responsible persons and distributors to communicate serious undesirable effects without delay to the competent authority of the Member State where the effect occurred.

  • Source, consumer and cosmetic-product details
  • Serious-effect description and available outcome
  • Product name and identification information
  • Authorized causality-assessment documentation
  • Notification form and authority-status tracking
Different Terms
Different Duties
Controlled Process
United States

Serious Adverse Event Support

Under MoCRA, the responsible person must report serious adverse events associated with cosmetic products to FDA within 15 business days and include a copy of the product label.

  • Responsible-person and product identification
  • Serious adverse-event record preparation
  • Retail-package label-copy coordination
  • New medical or other follow-up information tracking
  • Submission and confirmation record support
Reporting-support boundary: We may prepare records, forms, checklists, attachments, reconciliation logs and submission-status documentation. Authorized client personnel determine whether a report is valid, serious, related, reportable and ready for submission.
Post-Market Monitoring

Cosmetic Safety Trend Monitoring

Standardized records can support review of recurring effects, products, variants, batches, ingredients, consumer groups, countries, sources and seriousness patterns.

Effects by product and variant
Serious and non-serious patterns
Market and channel comparison
Batch and ingredient clusters
Follow-up and reporting ageing
Post-action recurrence review
Delivery Capabilities

Operational Support Across the Safety Lifecycle

Engagements may cover a complete managed workflow or selected activities integrated with the client’s existing safety, quality and regulatory teams.

Case Intake and Data Entry

Structured entry, source-document indexing, quality checks, case updates and status maintenance in approved systems.

Quality–Safety Reconciliation

Cross-link product-quality complaints and safety cases, compare shared data and exchange relevant updates.

Timeline and Due-Date Tracking

Monitor receipt, awareness, follow-up, review, reporting, reconciliation and closure milestones.

Document and Attachment Control

Index source records, photographs, labels, medical documents, forms, correspondence and submission confirmations.

Multilingual Safety Support

Language identification, approved translation, local follow-up support and structured global intake.

Backlog and Data Remediation

Missing-data review, record cleanup, duplicate checks, classification alignment, ageing reduction and reconciliation.

Operational Controls

Controls Supporting Traceable Safety Operations

The delivery model should be governed by approved procedures, quality agreements, privacy controls, trained roles and authorized oversight.

Market-specific terminology and workflow configuration
Privacy-conscious handling of consumer and medical information
Role-based access and documented user responsibilities
Source, receipt, awareness and transfer-date traceability
Documented follow-up attempts and unavailable-information status
Quality-control review and discrepancy management
Reporting, submission and confirmation-status logs
Authorized medical, safety and regulatory decision checkpoints
Frequently Asked Questions

Cosmetovigilance Services FAQs

General answers about cosmetic safety reports, serious reactions, follow-up, reporting support, assessment and outsourcing.

What is cosmetovigilance?

Cosmetovigilance is the structured collection, assessment support, monitoring and follow-up of undesirable health effects reported in connection with cosmetic products after they are marketed.

Is cosmetovigilance the same as cosmetic complaint management?

No. Cosmetic complaint management focuses on product and packaging quality. Cosmetovigilance focuses on undesirable health effects. One source report may require both pathways.

What types of effects can be recorded?

Reports may describe irritation, allergy, rash, swelling, burns, infection, eye effects, hair or nail effects, breathing symptoms or other health outcomes. Final medical terminology and assessment remain with authorized personnel.

Who decides whether a cosmetic reaction is serious?

The responsible organization and its authorized Safety, Medical and Regulatory personnel apply the relevant market definition and determine seriousness and reportability.

Can follow-up be conducted with consumers?

Yes. Approved follow-up may collect missing product, effect, treatment, outcome, healthcare and chronology information while respecting privacy, consent and local requirements.

Do you perform causality assessments?

We can organize the information and prepare documentation for authorized assessment. Final relationship or causality conclusions remain with the client’s qualified Safety or Medical personnel.

Can you prepare regulatory safety reports?

We can support data preparation, form completion, attachment control, quality checks, timeline tracking and submission-status documentation. Final reportability and submission authorization remain with the responsible organization.

Can cosmetovigilance services be outsourced?

Operational intake, data entry, follow-up, translation, document control, reporting preparation, reconciliation, monitoring and analytics may be outsourced under approved procedures, oversight, privacy controls and clear responsibility boundaries.

Cosmetic Safety Operations

Strengthen Your Cosmetovigilance Workflow

Discuss your cosmetic portfolio, markets, safety-report channels, case volumes, languages, systems, follow-up process, reporting responsibilities and trend-monitoring needs.

Request a Confidential Consultation
General Regulatory Context

Authoritative Cosmetovigilance Resources

Requirements differ by jurisdiction, market role, product classification and current law. Clients should follow current regulatory obligations and approved procedures.

Service and responsibility boundary: Pharma Complaint Hub provides operational, documentation, workflow, follow-up, translation, reconciliation, reporting preparation, data-management and trend-support services. We are not a cosmetic manufacturer, responsible person, healthcare provider or regulatory authority. Final medical assessment, relationship or causality assessment, seriousness classification, reportability, regulatory submission, consumer advice, product-risk, recall, market action, CAPA approval and case closure remain with the responsible organization and its authorized Safety, Medical, Quality and Regulatory personnel.